Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Capital Indonesia Tbk (BACA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Bank Capital Indonesia Tbk
Brigit Biofarmaka Teknologi Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Bank Capital Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Capital Indonesia Tbk trades at Rp101 (market cap 2.03T, 1.66M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank Capital Indonesia Tbk is far larger — about 12.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Capital Indonesia Tbk is more actively traded (1.66M versus 214.9K). Which is the better fit depends on your goals.

BACAOBAT
Market Cap
2.03T164.65B
Volume
1.66M214.9K
Lot
16.61K2.15K
Turnover
166.37M51.97M
Average Price
100.17241.85
Value
166.37M51.97M
Indicative Equilibrium Price
101240
Indicative Equilibrium Volume
20100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BACA
View details
OBAT
View details

About Bank Capital Indonesia Tbk

PT Bank Capital Indonesia (the company) was established under its original name of PT Bank Credit Lyonnais base on notarial deed No.139 of Mrs Siti Pertiwi, S.H, dated on Apr 20, 1989. The Company's articles of association has been amended several times, most recently by notarial deed No. 60 of Eliwati Tjitra, S.H., dated Jul 17, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering.

Read more on BACA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT